Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy
- PMID: 7742019
- DOI: 10.1165/ajrcmb.12.5.7742019
Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy
Abstract
T-lymphocyte (T-LC)-derived cytokines have been implicated in asthma pathogenesis. Activation of peripheral blood CD4 but not CD8 T-LC and a Th2-type pattern of elevated cytokine mRNA expression in BAL fluid T-LC have been observed in asthmatics, but the principal source (CD4 or CD8 T-LC) of these cytokines is unknown. Our objective was to measure expression of Th1- and Th2-type cytokine mRNA and spontaneous secretion of IL-3, IL-5, and GM-CSF by peripheral blood CD4 and CD8 T-LC from asthmatics before and after oral glucocorticoid therapy and non-asthmatic controls. We used in situ hybridization to detect mRNA expression in isolated CD4 and CD8 T-LC, and an in vitro eosinophil survival assay to detect secretion of IL-3, IL-5, and GM-CSF in T-LC culture supernatants. Comparing the asthmatics with the controls, elevated percentages of CD4 T-LC expressed mRNA encoding IL-5, IL-4, and GM-CSF (P < 0.02) but not IL-3, IL-2, or IFN-gamma. In CD8 T-LC, mRNA expression was generally low with no significant differences between the groups. In the asthmatics, the percentages of CD4 T-LC expressing IL-5 mRNA correlated with disease severity and the numbers of peripheral blood eosinophils (P < 0.01). Culture supernatants of asthmatic CD4 but not CD8 T-LC exhibited significantly higher (P = 0.0003) eosinophil survival-prolonging activity compared with controls, in which low activity was detected. Inhibition with anti-cytokine antibodies suggested that GM-CSF, and to a lesser extent IL-5 and IL-3, could account for this activity. After oral glucocorticoid therapy of the asthmatics, lung function improved and the percentages of CD4 T-LC expressing mRNA encoding IL-3, IL-5, and GM-CSF but not IL-2, IL-4, or IFN-gamma were reduced (P < 0.04). Secretion of eosinophil survival-prolonging activity by the CD4 T-LC was also reduced (P = 0.004). We conclude that peripheral blood CD4 but not CD8 T-LC from asthmatics express cytokine mRNA in a Th2-type pattern and show elevated secretion of cytokines prolonging eosinophil survival. Glucocorticoid therapy of asthmatics is associated with a reduction in the percentages of CD4 T-LC expressing IL-3, IL-5, and GM-CSF mRNA and secretion of the corresponding proteins.
Similar articles
-
Secretion of the eosinophil-active cytokines interleukin-5, granulocyte/macrophage colony-stimulating factor and interleukin-3 by bronchoalveolar lavage CD4+ and CD8+ T cell lines in atopic asthmatics, and atopic and non-atopic controls.Eur J Immunol. 1995 Oct;25(10):2727-31. doi: 10.1002/eji.1830251002. Eur J Immunol. 1995. PMID: 7589063
-
Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3.Am J Respir Cell Mol Biol. 1997 Jan;16(1):1-8. doi: 10.1165/ajrcmb.16.1.8998072. Am J Respir Cell Mol Biol. 1997. PMID: 8998072
-
Expression of activation markers and cytokine mRNA by peripheral blood CD4 and CD8 T cells in atopic and nonatopic childhood asthma: effect of inhaled glucocorticoid therapy.Pediatrics. 2002 Feb;109(2):E24. doi: 10.1542/peds.109.2.e24. Pediatrics. 2002. PMID: 11826234
-
IL-5 and IL-5 receptor in asthma.Mem Inst Oswaldo Cruz. 1997;92 Suppl 2:75-91. doi: 10.1590/s0074-02761997000800012. Mem Inst Oswaldo Cruz. 1997. PMID: 9698919 Review.
-
Cytokine binding to CD4+ inflammatory cells: implications for asthma.Am J Respir Crit Care Med. 1994 Nov;150(5 Pt 2):S59-62. doi: 10.1164/ajrccm/150.5_Pt_2.S59. Am J Respir Crit Care Med. 1994. PMID: 7952594 Review.
Cited by
-
Nitric oxide gas phase release in human small airway epithelial cells.Respir Res. 2009 Jan 19;10(1):3. doi: 10.1186/1465-9921-10-3. Respir Res. 2009. PMID: 19152703 Free PMC article.
-
Anti-inflammatory agents in allergic diseases.Clin Exp Immunol. 1995 Oct;102(1):1-5. doi: 10.1111/j.1365-2249.1995.tb06627.x. Clin Exp Immunol. 1995. PMID: 7554374 Free PMC article. Review. No abstract available.
-
New evidence of inflammation in asthma.Thorax. 2000 Oct;55 Suppl 2(Suppl 2):S59-60. doi: 10.1136/thorax.55.suppl_2.s59. Thorax. 2000. PMID: 10992562 Free PMC article. Review. No abstract available.
-
Immune mechanisms of childhood asthma.Thorax. 1999 Oct;54(10):938-46. doi: 10.1136/thx.54.10.938. Thorax. 1999. PMID: 10491459 Free PMC article. Review. No abstract available.
-
Systemic administration of olygodeoxynucleotides with CpG motifs at priming phase reduces local Th2 response and late allergic rhinitis in BALB/c mice.Inflammation. 2008 Feb;31(1):47-56. doi: 10.1007/s10753-007-9048-9. Epub 2007 Sep 12. Inflammation. 2008. PMID: 17849181
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials